Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multicenter, Randomized, Parallel-Controlled Study
Clinical trial NCT07149467 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07149467
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-10
- Primary completion
- 2026-12-31
- Enrollment
- 454
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.